US Top News and Analysis | Tesla is down sharply in 2026. JPMorgan sees even more declines ahead

Tesla is down sharply in 2026. JPMorgan sees even more declines ahead. The investment bank reiterated its underweight rating for the electric vehicle maker and maintained its $145 price target, which implies roughly 60% downside from Thursday's close. Analyst Ryan Brinkman advised investors to approach TSLA shares with a high degree of caution, noting that while technology and execution risks have diminished, expansion into higher-volume, lower-price segments carries greater risk relative to demand, execution, and competition.

JPMorgan lowered its 2026 earnings per share forecast for Tesla to $1.80 from $2, below consensus estimates, after the company delivered fewer vehicles than expected in the first quarter—around 358,000 compared to the anticipated 370,000. Despite acknowledging Tesla’s strengths, including its differentiated business model, appealing product portfolio, and leading-edge technology, the bank concluded these positives are more than offset by above-average execution risk, rising competition, brand-related controversy, and a valuation that appears to price in excessive optimism.

The call contrasts sharply with Wall Street consensus, as only 10 of the 54 analysts covering Tesla currently hold an underperform or sell rating, according to LSEG. While Tesla shares have fallen nearly 20% year-to-date, they remain up about 51% over the past 12 months, highlighting the divergence between short-term pessimism and longer-term gains.

Read more: https://www.cnbc.com/2026/04/06/tesla-is-down-sharply-in-2026-jpmorgan-sees-even-more-declines-ahead.html

#tesla #jpmorgan #electricvehicle #pricetarget #earnings-per-share

Citigroup upgrades Constellation Brands to 'Buy' from 'Neutral' with $175 price target, citing positive revenue momentum and historically low valuation, as shares rise 0.28% to $152.09 following the announcement.
#YonhapInfomax #ConstellationBrands #Citigroup #RatingUpgrade #PriceTarget #Valuation #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=110849
Citi Upgrades Constellation Brands to 'Buy' from 'Neutral'

Citigroup upgrades Constellation Brands to 'Buy' from 'Neutral' with $175 price target, citing positive revenue momentum and historically low valuation, as shares rise 0.28% to $152.09 following the announcement.

Yonhap Infomax
TD Cowen upgrades Rivian Automotive to 'Buy' with $20 price target, citing strong demand potential of 212,000-335,000 units annually for the upcoming mass-market R2 SUV priced at $45,000, significantly exceeding 2027 market consensus as the catalyst for U.S. EV market recovery.
#YonhapInfomax #RivianAutomotive #TDCowen #R2SUV #ElectricVehicle #PriceTarget #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=109280
TD Cowen Upgrades Rivian to 'Buy' - 'R2 to Lead EV Market Revival'

TD Cowen upgrades Rivian Automotive to 'Buy' with $20 price target, citing strong demand potential of 212,000-335,000 units annually for the upcoming mass-market R2 SUV priced at $45,000, significantly exceeding 2027 market consensus as the catalyst for U.S. EV market recovery.

Yonhap Infomax
Wall Street analysts raised Nvidia’s price targets after record earnings, with Citi, BofA, and Bernstein setting $300, citing robust AI demand and growth prospects.
#YonhapInfomax #Nvidia #PriceTarget #WallStreet #AIMarket #EarningsGrowth #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=107125
Wall Street Raises Nvidia Price Targets—Citi, BofA, Bernstein Set $300

Wall Street analysts raised Nvidia’s price targets after record earnings, with Citi, BofA, and Bernstein setting $300, citing robust AI demand and growth prospects.

Yonhap Infomax
Goldman Sachs forecasts Biohaven shares could surge nearly 100%, citing the company's promising pipeline for kidney disease treatments and a $23 price target.
#YonhapInfomax #GoldmanSachs #Biohaven #PriceTarget #KidneyDisease #BiotechPipeline #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=104493
Goldman Sachs Says Biohaven Shares Could Double

Goldman Sachs forecasts Biohaven shares could surge nearly 100%, citing the company's promising pipeline for kidney disease treatments and a $23 price target.

Yonhap Infomax
Canaccord Genuity, long bullish on MicroStrategy, slashed its price target by 61% to $185, citing Bitcoin's identity crisis, but maintained a 'Buy' rating as the company prepares to report earnings amid significant unrealized losses.
#YonhapInfomax #MicroStrategy #CanaccordGenuity #Bitcoin #PriceTarget #UnrealizedLosses #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=104006
'Bullish Surrender'—Canaccord Slashes MicroStrategy Price Target by 61%

Canaccord Genuity, long bullish on MicroStrategy, slashed its price target by 61% to $185, citing Bitcoin's identity crisis, but maintained a 'Buy' rating as the company prepares to report earnings amid significant unrealized losses.

Yonhap Infomax
Samsung Electronics Co. set a new record in South Korea's stock market, surpassing 1,000 trillion won in market capitalization intraday as shares surged, with brokerages raising price targets amid strong foreign investor demand and robust earnings outlook.
#YonhapInfomax #SamsungElectronics #MarketCapitalization #ForeignInvestors #PriceTarget #OperatingProfit #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=103809
Samsung Electronics Sets New Milestone in Korean Stock Market—Market Cap Surpasses 1,000 Trillion Won Intraday

Samsung Electronics Co. set a new record in South Korea's stock market, surpassing 1,000 trillion won in market capitalization intraday as shares surged, with brokerages raising price targets amid strong foreign investor demand and robust earnings outlook.

Yonhap Infomax
Wells Fargo and Bernstein have upgraded FedEx to ‘Overweight’ and sharply raised price targets, citing undervaluation and expectations for improved profitability ahead of the company’s Investor Day.
#YonhapInfomax #FedEx #WellsFargo #Bernstein #PriceTarget #InvestorDay #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=103769
Wells Fargo, Bernstein Raise FedEx Price Targets Ahead of Investor Day

Wells Fargo and Bernstein have upgraded FedEx to ‘Overweight’ and sharply raised price targets, citing undervaluation and expectations for improved profitability ahead of the company’s Investor Day.

Yonhap Infomax
William Blair upgraded Palantir to "Outperform" and raised its price target to $200, citing recent share price weakness and strong AI-driven growth ahead of earnings.
#YonhapInfomax #Palantir #WilliamBlair #PriceTarget #AIGrowth #EarningsForecast #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=103431
William Blair Raises Palantir Price Target to $200—'Stock Attractive Ahead of Earnings' - Yonhap Infomax

William Blair upgraded Palantir to "Outperform" and raised its price target to $200, citin

Yonhap Infomax
Jefferies recommends buying Meta Platforms as shares dip 2% in January, citing an attractive risk-reward profile and a $910 price target amid AI and capex concerns.
#YonhapInfomax #MetaPlatforms #Jefferies #PriceTarget #ArtificialIntelligence #CapitalExpenditures #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=101721
Jefferies Says Meta Is a Buy at Current Levels

Jefferies recommends buying Meta Platforms as shares dip 2% in January, citing an attractive risk-reward profile and a $910 price target amid AI and capex concerns.

Yonhap Infomax